TGen Drug Development

Category: Drugs & Pharmaceuticals

Advances in genomic discoveries and technologies are ushering in a new era of personalized medicine, and in the process, transforming the nature of drug development. As an affiliate of the Translational Genomics Research Institute (TGen), the Center for Translational Drug Development (TD2) is uniquely positioned to ensure your clinical development plan is a commercial success by providing the strategic preclinical and clinical trials study design for targeted drug development.